Better compliance to antihypertensive medications reduces cardiovascular risk
The DOI matches its Crossref record; 57 of the 59 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The effect of compliance with antihypertensive medications on the risk of cardiovascular outcomes in a population without a known history of cardiovascular disease has been addressed by a large population-based prospective, cohort study carried out by linking Italian administrative databases. METHODS: The cohort of 242 594 patients aged 18 years or older, residents in the Italian Lombardy Region, who were newly treated for hypertension during 2000-2001, was followed from index prescription until 2007. During this period patients who experienced a hospitalization for coronary or cerebrovascular disease were identified (outcome). Exposure to antihypertensive drugs from index prescription until the date of hospitalization or censoring was assessed. Proportional hazards models were fitted to assess the association between persistence on and adherence with antihypertensive drug therapy and outcome. Data were adjusted for several covariates. RESULTS: During an average follow-up of 6 years, 12 016 members of the cohort experienced the outcome. Compared with patients who experienced at least one episode of treatment discontinuation, those who continued treatment had a 37% reduced risk of cardiovascular outcomes (95% confidence interval 34-40%). Compared with patients who had very low drug coverage (proportion of days covered ≤ 25%), those at intermediate (from 51 to 75%) and high coverage (>75%) had risk reductions of 20% (16-24%) and 25% (20-29%), respectively. Similar effects were observed when coronary and cerebrovascular events were considered separately. CONCLUSIONS: In the real life setting, fulfillment compliance with antihypertensive medications is effective in the primary prevention of cardiovascular outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonadherence to antihypertensive treatment affects 10%-80% of hypertensive patients and is one of the key drivers of suboptimal BP control. 75-77”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [77]
In the citing paper
“and it is associated with an increased risk of cardiovascular events [45].”
Citations
Cites
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,824
Self-citationDiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177
Selected major risk factors and global and regional burden of disease
Ezzati, M., Lopez, A. D., Rodgers, A., Vander Hoorn, S., & Murray, C. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11403-6 · Cited by 3,594
Law, M. R., Morris, J. K., & Wald, N. J. (2009) · BMJ · doi:10.1136/bmj.b1665 · Cited by 2,775
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M., & Pajak, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,263
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis
Robin DiMatteo, M., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002) · Medical Care · doi:10.1097/00005650-200209000-00009 · Cited by 1,490
Worldwide prevalence of hypertension: a systematic review
Kearney, P. M., Whelton, M., Reynolds, K., Whelton, P. K., & He, J. (2004) · Journal of Hypertension · doi:10.1097/00004872-200401000-00003 · Cited by 1,140
Cited by
Items 201–300 of 365
Practical issues in medication compliance in hypertensive patients
Krzesinski, J.-M., & Leeman (2011) · Research Reports in Clinical Cardiology · doi:10.2147/rrcc.s12671 · Cited by 8
New blood pressure control goals, more rational but facilitating therapeutic inertia?
Mancia, G., & Fagard, R. H. (2013) · Journal of Hypertension · doi:10.1097/hjh.0000000000000005 · Cited by 7
Self-citationIdentifying personalized barriers for hypertension self-management from TASKS framework
Yang, J., Zeng, Y., Yang, L., Khan, N. A., Singh, S., Walker, R. L., Eastwood, R. L., & Quan, H. (2024) · BMC Research Notes · doi:10.1186/s13104-024-06893-7 · Cited by 17
Manolis, A. J., Karakasis, P., Patoulias, D., Doumas, M. N., Kallistratos, M. S., Thomopoulos, C., Koutsaki, M., Grassi, G. M., & Mancia, G. (2024) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-024-00687-5 · Cited by 7
Self-citationGiakoumidakis, K., Patelarou, E., Brokalaki, H., Bastaki, M., Fotos, N. V., Ifantopoulou, P., Christodoulakis, A., Chatziefstratiou, A. A., & Patelarou, A. E. (2024) · Healthcare · doi:10.3390/healthcare12090916 · Cited by 6
“…its management, increasing the risk of cardiovascular events, poor renal outcomes (such as end-stage kidney disease), and even mortality, whereas studies have shown that better medication adherence substantially reduces cardiovascular risks and events, including drug-related side effects [13,14].”
BackgroundEarly adherence to antihypertensive drugs and long‐term cardiovascular mortality in the “real world”
Salazar, M. R. (2021) · Journal of Clinical Hypertension · doi:10.1111/jch.14319 · Cited by 6
Groenland, E. H., Dasgupta, I., Visseren, F. L. J., van der Elst, K. C. M., Lorde, N., Lawson, A. J., Bots, M. L., & Spiering, W. (2022) · Blood Pressure · doi:10.1080/08037051.2022.2104215 · Cited by 8
Strategies to meet the need for long-term data
Chalmers, J. P., Woodward, M., Borghi, C., Manolis, A. J., & Mancia, G. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000987 · Cited by 7
Self-citationKalaitzidis, R., Panagiotopoulou, T., Stagikas, D., Pappas, K., Balafa, O. C., & Elisaf, M. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161117666190415112953 · Cited by 6
Mohan, A., Vadhariya, A., Majd, Z., Esse, T. W., Serna, O., & Abughosh, S. (2021) · Patient Education and Counseling · doi:10.1016/j.pec.2020.12.009 · Cited by 6
Autonomic dysfunction in programmed hypertension
Dissanayake, H. U., Skilton, M. R., & Polson, J. W. (2018) · Journal of Human Hypertension · doi:10.1038/s41371-018-0142-2 · Cited by 6
Shen, Y., Wang, T., Gao, M., Zhu, X., Zhang, X., He, C. G., Li, Y., & Sun, X. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s194667 · Cited by 11
Okamura, K., Yano, Y., Takamiya, Y., Shirai, K., & Urata, H. (2019) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2019.1693586 · Cited by 6
Impact of diastolic blood pressure threshold for the young population
Asayama, K., Kinoshita, Y., Watanabe, S., Ohkubo, T., Ando, T., Harada, A., Ohashi, Y., Ueshima, H., & Imai, Y. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002025 · Cited by 5
“Because reducing the number of daily antihypertensive agents improves adherence and increases the rate of blood pressure control [9,10], a single-pill combination therapy is a practical tool for achieving sufficient blood pressure control in the population as recommended in the 2018 ESC/ESH”
MethodGallo, G., Sarzani, R., Cicero, A. F. G., Genovese, S., Pirro, M., Gallelli, L., Faggiano, A., & Volpe, M. (2023) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-023-00570-9 · Cited by 8
Okamura, K., Shirai, K., Totake, N., Okuda, T., & Urata, H. (2017) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2017.1334798 · Cited by 5
Efanov, А. Y., Petrov, I. M., Petrova, Y. A., Vyalkina, Y. A., Починок, Е. М., Шоломов, И. Ф., Медведева, И. В., & Шалаев, С. В. (2018) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2018-4-43-48 · Cited by 5
Haff, N., Choudhry, N. K., Isaac, T., Bhatkhande, G., Jackevicius, C. A., Fischer, M. A., Solomon, D. H., Sequist, T. D., & Lauffenburger, J. C. (2022) · American Heart Journal · doi:10.1016/j.ahj.2022.10.083 · Cited by 5
The New A merican Guidelines on Hypertension: A Favorable Opinion
Mancia, G. (2014) · Journal of Clinical Hypertension · doi:10.1111/jch.12311 · Cited by 5
Self-citationKumar, V., Kumari, B., Rahat, E., & Fareed, S. (2019) · Cureus · doi:10.7759/cureus.4605 · Cited by 6
Home Blood Pressure Monitoring, Treatment Adherence and Hypertension Control
de la Sierra, A., Mihailidou, A., Wang, J.-G., Shimbo, D., & McManus, R. J. (2020) · Updates in Hypertension and Cardiovascular Protection · doi:10.1007/978-3-030-23065-4_8 · Cited by 5
Zhussupova, G., ЖАЛДЫБАЕВА, С. С., & Utepova, D. (2020) · Journal of Health Development · doi:10.32921/2225-9929-2020-36-84-100 · Cited by 8
Factors influencing medication adherence among patients with hypertension: a systematic reviewPreprint
Win, T., & Ruaisungnoen, S. B. A. W. (2021) · doi:10.17605/osf.io/zbc7u · Cited by 17
Apkhanova, T. V., Marchenkova, L., & Konchugova, T. V. (2025) · Bulletin of Rehabilitation Medicine · doi:10.38025/2078-1962-2025-24-5-142-157 · Cited by 8
Hartch, C. E., Dietrich, M. S., Lancaster, B., Mulvaney, S. A., & Stolldorf, D. P. (2024) · JMIR Human Factors · doi:10.2196/63653 · Cited by 8
A simple test to appreciate compliance to aliskiren treatment
Gosse, P., Coulon, P., Brossaud, J., & Corcuff, J. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834acb17 · Cited by 4
Ullah, M., Saha, S. K., Rahman, M. T., Karim, M. A., & Ahmed, R. (2019) · Cardiovascular Journal · doi:10.3329/cardio.v11i2.40409 · Cited by 6
For Debate: The 2023 European Society of Hypertension guidelines - cause for concern
Shantsila, E., Beevers, D. G., & Lip, G. Y. H. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003733 · Cited by 6
“…the following key reasons for failure to achieve BP control: physician inertia to adequately up-titrate treatment [10], low patient adherence to treatment ( 50 Journal of Hypertension based on prescription refilling) [11], higher rates of treatment nonadherence with more medications used [12].”
BackgroundLi, X., Bijlsma, M. J., de Vos, S., Bos, J., Mubarik, S., Schuiling‐Veninga, C. C. M., & Hak, E. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1357567 · Cited by 6
Morabito, G., Rea, F., Corrao, G., & Mancia, G. (2025) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcae116 · Cited by 5
Self-citationBlood pressure control in the hypertensive population. Is the trend favourable?
Mancia, G. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32836184cf · Cited by 5
Self-citationAdherence to taking medicines as a basis for prevention of cardiovascular diseases
Napalkov, D. A., & Sokolova, A. A. (2019) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2019-5-54-59 · Cited by 4
Kobalava, Z. D., Троицкая, Е. А., Маркова, М. А., & Khruleva, Y. (2019) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2019-25-3-285-294 · Cited by 4
Mandini, S., Conconi, F., Mori, E., Grazzi, G., & Mazzoni, G. (2020) · Sport Sciences for Health · doi:10.1007/s11332-020-00620-y · Cited by 5
Harrison, M. A., Marfo, A. F. A., Buabeng, K. O., Annan, A., Nelson, F., Boateng, D. P., Nkansah, F. A., Aboagye, G. O., & Ankrah, D. (2023) · Health Science Reports · doi:10.1002/hsr2.1185 · Cited by 4
Kichou, B., Henine, N., Himeur, Y., Kichou, L., Saïd, M. A., Mazeghrane, A., & Hammouche, A. (2019) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2019.07.002 · Cited by 6
Schäfer, A.-K. C., Kuczera, T., Wurm‐Kuczera, R., Müller, D., Born, E., Lipphardt, M., Plüß, M., Wallbach, M., & Koziolek, M. J. (2021) · Journal of Clinical Hypertension · doi:10.1111/jch.14302 · Cited by 8
Васильевна, К. А., Романенко, Т. С., Vygodin, V. A., & Fitilev, S. B. (2015) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2015-11-3-238-246 · Cited by 4
“sequently lowers the risk of target-organs damage and cardiovascular complications [3,4] and promotes the reduction in health care system resources expenditures [5].”
BackgroundQiu, B., Song, H., Ding, C., Sun, X., Du, R., Yang, H., Bai, W., & Dong, Z. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1264321 · Cited by 3
“Moreover, adherence to cardioprotective treatments can reduce morbidity and mortality (Simpson et al., 2006; Corrao et al., 2011).”
BackgroundPark, J., Chung, H., Kim, N. Y., Kim, N. Y., Hong, S. H., Kim, K., & Park, J. Y. (2024) · Drugs in R&D · doi:10.1007/s40268-024-00460-y · Cited by 5
Analysis of Adherence to Antihypertensive Drug Treatment in an Argentinean Cohort
Espeche, W. G., Sabio, R., Díaz, A., Parodi, R., Sisnieguez, C. E. L., Flores, R. A., Poppe, S., Altube, J., Grimaldi, D., & Salazar, M. R. (2020) · International Journal of Cardiovascular Sciences · doi:10.36660/ijcs.20190069 · Cited by 3
Level of hypertension treatment adherence during pandemic
Petkova, V. B., Peneva, A., Andreevska, K., Hristov, Е., Grekova, D., Тодорова, А., Tsvetkova, A., & Dimitrov, M. V. (2023) · Pharmacia · doi:10.3897/pharmacia.70.e109440 · Cited by 3
Desideri, G., Cipelli, R., Pegoraro, V., Ripellino, C., Miroddi, M., Meto, S., Gori, M., & Fabrizzi, P. (2024) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2328652 · Cited by 3
Management of adherence-based treatment. Consensus document – clinical guidelines. English version
Nikolaev, N., Martynov, A., Skirdenko, Y. P., Anisimov, V. N., Vasilieva, I. A., Vinogradov, O. I., Vinogradov, O. I., Лазебник, Л. Б., & Poddubnaya, I. V. (2021) · Medical news of the North Caucasus · doi:10.14300/mnnc.2021.16029 · Cited by 3
Europäische Hypertonieleitlinien 2018 – was ändert sich?
Jung, S., & Schmieder, R. E. (2019) · Der Internist · doi:10.1007/s00108-018-0552-9 · Cited by 3
Gilyarevskiy, S. R., Георгиевна, Б. Н., Golshmid, M. V., Kuzmina, I. M., & Andreeva, I. G. (2021) · Eurasian heart journal · doi:10.38109/2225-1685-2021-2-92-102 · Cited by 4
A new scope and a vision for record linkage studies
Corrao, G., & Vecchia, C. L. (2022) · Epidemiology Biostatistics and Public Health · doi:10.2427/9036 · Cited by 3
Self-citationSingle-pill combinations for hypertension: first line treatment for all?
Shao, L., Chan, P., Tomlinson, B., Zhang, Y., & Liu, Z.-M. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1541444 · Cited by 3
Tătar, R., Mărușteri, M., Cristescu, L., Şulea, A. P., Varga, A., & Ţilea, I. (2025) · Patient Preference and Adherence · doi:10.2147/ppa.s548210 · Cited by 2
Virdis, A., Tocci, G., Muiesan, M. L., Desideri, G., Viazzi, F. C., Albini, F. L., Sarzani, R., Gallo, G., Grassi, G. M., & Volpe, M. (2025) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-025-00761-6 · Cited by 3
Adherence to antihypertensive medications in rural Lao PDR: a prospective observational study
Takahashi, E., Vilay, P., Chanthakoumane, K., Pongvongsa, T., Kounnavong, S., Kano, S., Kobayashi, J., & Nonaka, D. (2021) · Tropical Medicine and Health · doi:10.1186/s41182-021-00374-4 · Cited by 5
Li, X., Steenhuis, D., Bijlsma, M. J., de Vos, S., Mubarik, S., Bos, J., Schuiling‐Veninga, C. C. M., & Hak, E. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s479120 · Cited by 2
Yi, Q., Yang, Y. X., Ru-jun, A., Huang, H., Ouyang, M., & Dai, J. (2015) · PubMed · doi:10.11817/j.issn.1672-7347.2015.11.016 · Cited by 2
A Review on Hypertension: Practice and Diagnosis
Islam, M., Chaudhuri, I., Islam, M. S., & Kamrujjaman, M. (2023) · Journal of Biology and Life Science · doi:10.5296/jbls.v14i2.20848 · Cited by 6
Negri, E., Rossi, M., Bonifazi, M., Franchi, M., Carioli, G., Zocchetti, C., Corrao, G., & Vecchia, C. L. (2022) · Epidemiology Biostatistics and Public Health · doi:10.2427/9016 · Cited by 2
“diabetes, dyslipidemia, obesity, cardiovascular, renal, respiratory, neurological and hepatic chronic diseases), we will retrieve hospitalizations reporting these diseases, and we will look for prescriptions of drugs related to these diseases in the outpatient drug prescription database, relying on a previously develo…”
BackgroundMethodSelf-citationQualitative Assessments of Adherence
Burnier, M., & Wuerzner, G. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-76593-8_2 · Cited by 2
Okamura, K., Shirai, K., Miyazaki, M., Okuda, T., Takamiya, Y., Goto, M., & Urata, H. (2019) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3558 · Cited by 2
Relationship Between Medication Adherence and Hypertension Status in Public Health Center
Lestari, P. A. L., Suastika, L. O. S., & Widyadharma, I. P. E. (2019) · International Journal of Medical Reviews and Case Reports · doi:10.5455/ijmrcr.medicationadherenceandhypertension-status-public-health-center · Cited by 2
Should blood pressure ≥130/80 mm Hg be considered as a cardiovascular disease?
Tadić, M., & Cuspidi, C. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13607 · Cited by 2
Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement
Buffolo, F., Sconfienza, E., Burrello, J., Losano, I., Mengozzi, G., Priolo, G., Avataneo, V., D’Avolio, A., Veglio, F., Rabbia, F., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.668843 · Cited by 4
“Poor compliance to anti-hypertensive prescriptions has been associated with increased risk of cardiovascular events (Corrao et al., 2011), heart failure (Perreault et al.”
Background[Doctor-patient relationship and therapeutic adherence in patients with arterial hypertension].
Peña-Valenzuela, A. N., Ruiz-Cervantes, W., Barrios-Olán, C., & Chávez-Aguilasocho, A. I. (2023) · PubMed Central · Cited by 12
Rabbitt, L., Curneen, J. M. G., Hobbins, A. P., Browne, D. P., Joyce, M., Lappin, D. W. P., McEvoy, J. W., Gillespie, P., & Dennedy, M. C. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003535 · Cited by 2
Ranasinghe, P. D., Manchanayake, M., Perera, T., Liyanage, S., & Webb, D. J. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003952 · Cited by 3
Grant, A. M. (2013) · CUNY Academic Works (City University of New York) · Cited by 4
Need for fixed combination therapy in type-2 diabetes: Findings from the SMART study
Bruno, R. M., & Taddei, S. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318794261 · Cited by 2
Eltayeb, A., & Khong, T. K. (2022) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2022.000014 · Cited by 3
Daskalopoulou, S. S., Quintanilla, H. P., Brzozowska-Villatte, R., & on behalf of the Study Investigators (2024) · Advances in Therapy · doi:10.1007/s12325-024-03091-6 · Cited by 4
Corazolla, E. M., Langeveld, M., Brands, M. M. M. G., Sjouke, B., & Hollak, C. E. M. (2025) · JIMD Reports · doi:10.1002/jmd2.70003 · Cited by 1
Adherence to antihypertensive therapy is a way to improve cardiovascular prognosis
Kosmacheva, E. D., Геннадьевна, К. О., Георгиевна, П. Г., & Agafonova, A. О. (2025) · Eurasian heart journal · doi:10.38109/2225-1685-2025-2-44-51 · Cited by 2
Minimizing Adverse Effects in Hypertension Treatment
McDermott, M. M., & Persell, S. D. (2026) · JAMA · doi:10.1001/jama.2026.7685 · Cited by 1
Okamura, K., & Urata, H. (2015) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2015.69083 · Cited by 1
“One cause of difficulty in controlling BP is poor adherence to medication, while good adherence can significantly improve control and reduce the risk of cardiovascular disease [19]-[21].”
BackgroundDrevenhorn, E., Bengtson, A., Nyberg, P., & Kjellgren, K. I. (2014) · Pragmatic and Observational Research · doi:10.2147/por.s58352 · Cited by 1
A ramipril versus ramipril/amlodipin fix kombináció egyéves perzisztenciája hypertoniás betegekben
Simonyi, G., & Ferenci, T. (2017) · Orvosi Hetilap · doi:10.1556/650.2017.30882 · Cited by 1
Mancia, G., Rea, F., & Corrao, G. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-76593-8_5 · Cited by 2
Self-citationBlood Pressure Variability and its Significance
Desai, N., Venkatesh, C. R., Sunil, S., Kulkarni, P., & Mahadevappa, M. (2017) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/13035_7 · Cited by 1
Management of resistant hypertension
Holaj, R. (2011) · Cor et Vasa · doi:10.33678/cor.2011.108 · Cited by 1
Kalaitzidis, R., Balafa, O. C., Dounousi, E. C., Stagikas, D., & Tsimihodimos, V. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161119666201120160104 · Cited by 1
The Benefits of Implementing Supervisory Board in the Healthcare System of Kazakhstan
Saiynov, M., & Dyussengalieva, G. (2020) · Journal of Health Development · doi:10.32921/2225-9929-2020-2-37-37-42 · Cited by 1
SWOT analysis of the Human Resource Management Service of Medical Organizations in Kazakhstan
Baiganova, Z., Magzumova, R., Delellis, N. O., & Tulegenova, A. (2020) · Journal of Health Development · doi:10.32921/2225-9929-2020-2-37-31-36 · Cited by 1
Inferring medication adherence from time‐varying health measures
Hunter, K. B., Glickman, M. E., & Campos, L. F. (2022) · Statistics in Medicine · doi:10.1002/sim.9351 · Cited by 1
Kristin, E., Dinarti, L. K., Febrinasari, R. P., Pratiwi, W. R., Yasmina, A., & Jaya, S. I. (2023) · INDONESIAN JOURNAL OF PHARMACY · doi:10.22146/ijp.5499 · Cited by 1
Гаранин, А. А., Рубаненко, А. О., & Trusov, Y. A. (2024) · Современные проблемы науки и образования · doi:10.17513/spno.33302 · Cited by 1
The Experiences of Black Men Living with Hypertension in Ontario, Canada: A Critical Narrative Study
Haile, R. (2014) · Scholarship@Western (Western University) · Cited by 1
ANTI-HYPERTENSIVE TREATMENT AND LIFESTYLE COMPLIANCE ON PRASLIN ISLAND, SEYCHELLES
Edo, T. A., & Villiers, L. D. (2012) · Unisa Institutional Repository (University of South Africa) · Cited by 1
Mancia, G., & Fagard, R. H. (2013) · Cited by 1
Self-citationQuaschning, K., Körner, M., & Wirtz, M. A. (2019) · Die Rehabilitation · doi:10.1055/a-0883-3856 · Cited by 1
Vachulová, A. (2019) · Vnitřní lékařství · doi:10.36290/vnl.2019.129 · Cited by 2
Quaschning, K., & Körner, M. (2020) · Die Rehabilitation · doi:10.1055/a-1242-9562 · Cited by 1
“768986 [15] Corrao G, Parodi A, Nicotra F et al.”
BackgroundInfluentialImpact of medication adherence on the efficacy of Baroreflex activation therapy
Schäfer, A.-K. C., Müller, D., Born, E., Mühlhaus, M., Lüders, S., Wallbach, M., & Koziolek, M. J. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14540
Mancia, G., & Fagard, R. H. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000277 · Cited by 1
Self-citationZhou, J., Shang, L., Bao, Y., Cheng, Y., Huang, R., Kong, D., Gu, N., & Ma, A. (2023) · Research Square · doi:10.21203/rs.3.rs-3135231/v1 · Cited by 1
(The Development of the Economic Model of the Drug Supply of the Population)Preprint
Avxentieva, M., Omelyanovsky, V. V., & Сура, М. В. (2014) · SSRN Electronic Journal · doi:10.2139/ssrn.2597498
Mancia, G., & Fagard, R. H. (2016)
Self-citationBetter compliance to antihypertensive medications reduces cardiovascular risk
Elliott, W. J. (2012) · Yearbook of Cardiology · doi:10.1016/j.ycar.2012.02.026
Chronic lower limb peripheral arterial disease
Forsyth, J. M. (2015) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738015592043
Lapi, F., Moschini, M., Bonaiuti, R., Di, M., Benemei, P. S., Coppini, R., Vannacci, A., Mugelli, A., Mortimer, S., Davis, B. A., et al. (2013)
Adherence to Medications in Uncontrolled Hypertension
Burnier, M., & Wuerzner, G. (2016) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-34141-5_11
19. Earthquake, cardiovascular diseases and implications for public health
TAKAHASHI, J. C., & Shimokawa, H. (2015) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-806-3_19
Use of Fixed-Dose Combinations in Hypertension and Cardiovascular Disease Prevention
Volpe, M., Tocci, G., & Gallo, G. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-76593-8_17
Metadata
- Authors
- Corrao, G., Parodi, A., Nicotra, F., Zambon, A., Merlino, L., Cesana, G., & Mancia, G.
- Affiliations
- University of Milano-Bicocca (IT)
- University of Milan (IT)
- Regione Lombardia (IT)
- IRCCS Istituto Auxologico Italiano (IT)
- Corresponding author
- Corrao, Giovanni
- Venue
- Journal of Hypertension
- Published
- 2011-03
- Volume
- 29
- Issue
- 3
- Pages
- 610-618
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W1970957826
- Cited by
- 367
- References
- 59
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 33 · 2023: 26 · 2022: 26 · 2021: 35 · 2020: 33 · 2019: 33 · 2018: 29 · 2017: 22 · 2016: 17 · 2015: 18 · 2014: 25 · 2013: 21 · 2012: 10
- FWCI
- 11.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Funders
- Regione Lombardia
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Keywords
- antihypertensive medication adherence, hypertension, cardiovascular risk, cardiovascular hospitalization, coronary disease, cerebrovascular disease, primary prevention, treatment persistence, proportion of days covered
- MeSH terms
- Adult, Aged, Antihypertensive Agents, Cardiovascular Diseases, Female, Humans, Hypertension, Male, Middle Aged, Prospective Studies, Risk, Cohort Studies, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.